VRTX vs. SHEL
Compare and contrast key facts about Vertex Pharmaceuticals Incorporated (VRTX) and Shell plc (SHEL).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VRTX or SHEL.
Correlation
The correlation between VRTX and SHEL is 0.53, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
VRTX vs. SHEL - Performance Comparison
Loading data...
Key characteristics
VRTX:
0.02
SHEL:
-0.22
VRTX:
0.32
SHEL:
-0.10
VRTX:
1.05
SHEL:
0.99
VRTX:
0.13
SHEL:
-0.23
VRTX:
0.35
SHEL:
-0.54
VRTX:
8.92%
SHEL:
7.94%
VRTX:
28.41%
SHEL:
23.04%
VRTX:
-91.77%
SHEL:
-67.46%
VRTX:
-16.40%
SHEL:
-7.75%
Fundamentals
VRTX:
$112.83B
SHEL:
$197.06B
VRTX:
-$3.82
SHEL:
$4.38
VRTX:
2.53
SHEL:
1.46
VRTX:
10.17
SHEL:
0.70
VRTX:
6.62
SHEL:
1.10
VRTX:
$11.09B
SHEL:
$281.07B
VRTX:
$9.54B
SHEL:
$42.59B
VRTX:
-$228.00M
SHEL:
$54.83B
Returns By Period
In the year-to-date period, VRTX achieves a 7.28% return, which is significantly lower than SHEL's 9.08% return. Over the past 10 years, VRTX has outperformed SHEL with an annualized return of 13.13%, while SHEL has yielded a comparatively lower 5.56% annualized return.
VRTX
7.28%
-10.78%
-11.84%
0.48%
9.33%
13.13%
SHEL
9.08%
8.89%
5.32%
-5.12%
22.06%
5.56%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
VRTX vs. SHEL — Risk-Adjusted Performance Rank
VRTX
SHEL
VRTX vs. SHEL - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Vertex Pharmaceuticals Incorporated (VRTX) and Shell plc (SHEL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
VRTX vs. SHEL - Dividend Comparison
VRTX has not paid dividends to shareholders, while SHEL's dividend yield for the trailing twelve months is around 4.11%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VRTX Vertex Pharmaceuticals Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SHEL Shell plc | 4.11% | 4.39% | 3.76% | 3.48% | 3.78% | 5.44% | 6.14% | 5.48% | 4.79% | 5.88% | 6.98% | 4.72% |
Drawdowns
VRTX vs. SHEL - Drawdown Comparison
The maximum VRTX drawdown since its inception was -91.77%, which is greater than SHEL's maximum drawdown of -67.46%. Use the drawdown chart below to compare losses from any high point for VRTX and SHEL. For additional features, visit the drawdowns tool.
Loading data...
Volatility
VRTX vs. SHEL - Volatility Comparison
Vertex Pharmaceuticals Incorporated (VRTX) has a higher volatility of 13.40% compared to Shell plc (SHEL) at 5.66%. This indicates that VRTX's price experiences larger fluctuations and is considered to be riskier than SHEL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
VRTX vs. SHEL - Financials Comparison
This section allows you to compare key financial metrics between Vertex Pharmaceuticals Incorporated and Shell plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
VRTX vs. SHEL - Profitability Comparison
VRTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported a gross profit of 2.41B and revenue of 2.77B. Therefore, the gross margin over that period was 86.9%.
SHEL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Shell plc reported a gross profit of 12.71B and revenue of 69.23B. Therefore, the gross margin over that period was 18.4%.
VRTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported an operating income of 630.10M and revenue of 2.77B, resulting in an operating margin of 22.8%.
SHEL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Shell plc reported an operating income of 9.47B and revenue of 69.23B, resulting in an operating margin of 13.7%.
VRTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported a net income of 646.30M and revenue of 2.77B, resulting in a net margin of 23.3%.
SHEL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Shell plc reported a net income of 4.78B and revenue of 69.23B, resulting in a net margin of 6.9%.